SUPN
Supernus Pharmaceuticals Inc
Price:  
32.03 
USD
Volume:  
590,538.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Relative Valuation

-16.8%
Upside

As of 2025-06-15, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 26.65 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.03 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -16.8%.

The range of the Relative Valuation is 15.50 - 32.51 USD.

Range Selected
Trailing P/E multiples 14.0x - 29.4x 22.0x
Forward P/E multiples 18.0x - 21.5x 20.4x
Fair Price 15.50 - 32.51 26.65
Upside -51.6% - 1.5% -16.8%
32.03 USD
Stock Price
26.65 USD
Fair Price

SUPN Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 28.97
2025-06-12 29.63
2025-06-11 29.98
2025-06-10 30.08
2025-06-09 30.09
2025-06-06 29.98
2025-06-05 29.25
2025-06-04 29.21
2025-06-03 29.15
2025-06-02 28.86
2025-05-30 28.67
2025-05-29 28.65
2025-05-28 29.07
2025-05-27 29.48
2025-05-23 29.03
2025-05-22 28.97
2025-05-21 29.51
2025-05-20 30.02
2025-05-19 29.89
2025-05-16 30.23
2025-05-15 29.37
2025-05-14 28.52
2025-05-13 29.19
2025-05-12 29.07
2025-05-09 28.67
2025-05-08 28.52
2025-05-07 27.98
2025-05-06 29.33
2025-05-05 29.29
2025-05-02 29.70
2025-05-01 29.35
2025-04-30 29.37
2025-04-29 29.38
2025-04-28 29.16
2025-04-25 29.14
2025-04-24 28.35
2025-04-23 27.89
2025-04-22 27.89
2025-04-21 27.39
2025-04-17 27.82
2025-04-16 27.77
2025-04-15 28.45
2025-04-14 28.58
2025-04-11 28.64
2025-04-10 28.10
2025-04-09 28.72
2025-04-08 27.71
2025-04-07 29.18
2025-04-04 29.61
2025-04-03 29.38